NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England
A Contract Award Notice
by NHS ENGLAND NORTH WEST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £2M
- Sector
- HEALTH
- Published
- 16 Mar 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Manchester
2 buyers
- NHS England North West Manchester
1 supplier
- Manchester University Trust Manchester
Description
Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.
Total Quantity or Scope
Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The Relevant Authority is intending to award a contract to the existing provider following Direct Award Process C. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by 27 March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. The contract will commence on 01 April 2026 and conclude on 31 March 2029.
Award Detail
| 1 | Manchester University Trust (Manchester)
|
Award Criteria
| The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100.0 |
| The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Award on basis of price and quality.
Legal Justification
The Relevant Authority intends to issue a contract via Direct Award Process C. The Relevant Authority has taken into account the key criteria and applied the basic selection criteria, and is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.
Other Information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by 27 March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: necsu.neprocurement@nhs.net The award decision was made on 16 March 2026 by the North West Specialised Commissioning Senior Leaders Team. The Relevant Authority, as part of the Direct Award C process, have reviewed the key criteria. The evidence shows that the Provider can satisfy the proposed new contract. The information gathered evidences that the incumbent provider meets the key criteria and gives assurance that they can continue to provide the service within the new contract. The current Provider is providing a quality service which meets the needs of the population they serve and is continually addressing and reducing inequalities in both service, access and outcomes. It shows the current provider is treating both patients and staff with equality and are continually seeking improvements in social value including their environment. All involved in the process completed a conflict of interest declaration. No conflicts were identified.
Reference
- FTS 023649-2026